Natco Pharma Limited
Equibles does not estimate personal net worth.
Rajesh Chabiam has spoken on 3 earnings calls across 1 company, most recently for Natco Pharma Limited on November 13, 2026. Natco Pharma Limited is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“See, as you are aware, we did a rights issue, which basically what it does also, the cap structure is now changed a bit. Because of that, we have to resubmit the file to SEBI.”
“No, so basically for the quarter there was a loss, right, but the goal and our expectation for the year is to break-even. So, if you look at overall scenario for the crop health is very, very seasonal, right, Rashmi?”
“Good afternoon and welcome, everyone, to NACo's conference call, discussing our earnings results for the fourth quarter of FI26, which ended March 31, 2026. During this call, we may be making certain forward-looking statements, which are not necessarily historical facts.”
Natco Pharma Limited
Transcript header (unverified)
Natco Pharma Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call for the Quarter Ended September 30, 2026
Natco Pharma Limited
Earnings Call
Natco Pharma Limited
Earnings Call for the Quarter Ended March 31, 2026
Natco Pharma Limited
